NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy (Q44778772)

6 December 2017

title

NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy (English)

1 reference

6 December 2017

1 reference

chronic heart failure

1 reference

8

Michal Tendera

1 reference

6 December 2017

5

Henry Krum

1 reference

6 December 2017

13

Hugo A Katus

1 reference

6 December 2017

7

Jean L Rouleau

1 reference

6 December 2017

Franz Hartmann

1

1 reference

6 December 2017

Milton Packer

2

1 reference

6 December 2017

Andrew J S Coats

3

1 reference

6 December 2017

Michael B Fowler

4

1 reference

6 December 2017

Paul Mohacsi

6

1 reference

6 December 2017

Alain Castaigne

9

1 reference

6 December 2017

Jürgen Trawinski

10

1 reference

6 December 2017

Ildiko Amann-Zalan

11

1 reference

6 December 2017

Silke Hoersch

12

1 reference

6 December 2017

language of work or name

1 reference

1 March 2004

1 reference

European Journal of Heart Failure

6 December 2017

published in

1 reference

6 December 2017

volume

6

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

343-350

1 reference

Epidemiologic and economic impact of advanced heart failure

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Neurohormonal interactions and adaptations in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Neuroendocrine activity in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Activation of neurohumoral systems in postinfarction left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Risk stratification in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Effect of beta-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Atrial natriuretic peptide and antihypertensive action due to beta-blockade in essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Beta-adrenoceptor blockade potentiates exercise-induced release of atrial natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

The circulating renin-angiotensin system during treatment with metoprolol or captopril in patients with heart failure due to non-ischaemic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.01.009

10.1016/J.EJHEART.2004.01.009

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference